Report overview
Lithium carbonate, also known as lithium salt, is the most widely used mood stabilizer in psychiatry. In contrast to tricyclic anti-depressants, lithium can significantly inhibit the release of norepinephrine and dopamine in the central nervous system and increase the re-uptake of neurons to exert an anti-manic effect. In the psychiatric department, lithium carbonate is used as a mood stabilizer for the treatment of mania and is regarded as a specific drug for bipolar disorder, as well as for the prevention of mania and depression. In addition, lithium carbonate is also used in the treatment of schizoaffective psychosis, schizophrenia, epilepsy caused by mental disorders, and used to control the excitement of the patient's impulsive aggressive behaviour.
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Grade Lithium Carbonate, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Grade Lithium Carbonate. This report contains market size and forecasts of Pharmaceutical Grade Lithium Carbonate in global, including the following market information:
Global Pharmaceutical Grade Lithium Carbonate Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global Pharmaceutical Grade Lithium Carbonate Market Sales, 2018-2023, 2024-2032, (Ton)
Global top five Pharmaceutical Grade Lithium Carbonate companies in 2022 (%)
The global Pharmaceutical Grade Lithium Carbonate market was valued at US$ 99.8 million in 2022 and is projected to reach US$ 145.7 million by 2029, at a CAGR of 5.6% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The major players in global Pharmaceutical Grade Lithium Carbonate market include Albemarle, Essential Pharma, Livent, etc. The top 3 players occupy about 45% shares of the global market. Americas and Europe are main markets, they occupy about 80% of the global market. 0.985-0.99 is the main type, with a share over 70%. Lithium Carbonate Sustained-release Tablets is the main application, which holds a share about 95%.
We surveyed the Pharmaceutical Grade Lithium Carbonate manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pharmaceutical Grade Lithium Carbonate Market, by Type, 2018-2023, 2024-2032 ($ Millions) & (Ton)
Global Pharmaceutical Grade Lithium Carbonate Market Segment Percentages, by Type, 2022 (%)
0.98
0.99
Other
Global Pharmaceutical Grade Lithium Carbonate Market, by Application, 2018-2023, 2024-2032 ($ Millions) & (Ton)
Global Pharmaceutical Grade Lithium Carbonate Market Segment Percentages, by Application, 2022 (%)
Tablets
Capsule
Global Pharmaceutical Grade Lithium Carbonate Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions) & (Ton)
Global Pharmaceutical Grade Lithium Carbonate Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pharmaceutical Grade Lithium Carbonate revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Pharmaceutical Grade Lithium Carbonate revenues share in global market, 2022 (%)
Key companies Pharmaceutical Grade Lithium Carbonate sales in global market, 2018-2023 (Estimated), (Ton)
Key companies Pharmaceutical Grade Lithium Carbonate sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Livent
Albemarle
Globe Quimica
Hubei Rison Chemical
Axiom Lithium
Outline of Major Chapters:
Chapter 1: Introduces the definition of Pharmaceutical Grade Lithium Carbonate, market overview.
Chapter 2: Global Pharmaceutical Grade Lithium Carbonate market size in revenue and volume.
Chapter 3: Detailed analysis of Pharmaceutical Grade Lithium Carbonate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pharmaceutical Grade Lithium Carbonate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Pharmaceutical Grade Lithium Carbonate capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
